Skip to main content
Log in

Various S-GOT/S-GPT Ratios in Nonviral Liver Disorders and Related Physical Conditions and Life-Style

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The relationship between the GOT/GPT ratio in nonviral liver disorders and underlying physical condition and life-style were evaluated. The subjects were 12,808 male railway company workers who underwent an annual health checkup. Nonviral liver disorders were defined as elevated transaminases (GOT > 76 IU/liter or GPT > 86 IU/liter, while negative for hepatitis B and C markers (282 cases). Controls were 9783 males with normal findings for GOT, GPT, and γ-GTP. By logistic regression analysis, GOT-dominant liver disorders were significantly related to alcohol consumption, hypertriglyceridemia, and diabetes mellitus. They were still significant on multivariate analysis. GPT-dominant liver disorders were significantly related to obesity, less exercise, hypercholesterolemia, and hypertriglyceridemia. Obesity and hypercholesterolemia were significant on multivariate analysis. In conclusion, the relationship between hypertriglyceridemia or diabetes mellitus and GOT-dominant disorders, which was not explained empirically, could indicate another pathogenesis for nonviral liver disorders, such as underlying insulin resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Sherlock S, Dooley J: Chronic hepatitis. In Diseases of the Liver and Biliary System. London, Blackwell Science, pp 303–335

  2. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12(4 Pt 1):671–675, 1990

    Google Scholar 

  3. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859–2865, 1996

    Google Scholar 

  4. Okubo A, Kameyama S: The transaminase (aminotransferase). In The Approach of Determination of Serum Enzyme to Abnormal-Disease State. M Kitamura (ed). Tokyo, Igakushoin, 1985, pp 1–28, (in Japanese)

    Google Scholar 

  5. Colon JA, Kaplan MM: The SGOT/SGPT ratio: An indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979

    Google Scholar 

  6. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H: Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 13(6):1040–1043, 1991

    Google Scholar 

  7. Kondo Y, Hibino K: The viral hepatitis. Nipponrinsho, Suppl. for liver diseases. Tokyo, Nipponrinsho-sha, 1998, pp 30–32 (in Japanese)

    Google Scholar 

  8. Furuta S: The clinic of the hepatitis type C. J Jpn Soc Intern Med 83:1430–1438, 1993

    Google Scholar 

  9. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M: Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 34(suppl 2): 13–16, 1993

    Google Scholar 

  10. SPSS: Base 9.0J for Windows User's Guide. Chicago, SPSS Inc, 1999

    Google Scholar 

  11. SPSS: Advanced Models 9.0. Chicago, SPSS Inc, 1999

    Google Scholar 

  12. SPSS: Regression Models 9.0. Chicago, SPSS Inc, 1999

    Google Scholar 

  13. Saito Y, Yagyu K, Hattori Y, Ohno K, Okamoto N, Takahashi A, Ohtsuka S, Ohtsuka T, Maeda K, Okamoto K, Kato T: A study on fatty in health examination participants. Jpn J Hyg 44:953–961, 1989

    Google Scholar 

  14. Braillon A, Capron JP, Herve MA, Degott C, Quenum C: Liver in obesity. Gut 26(2):133–139, 1985

    Google Scholar 

  15. Ishii M, Toyota T: Electron microscopic study of lipoproteinlike particles and lipid droplets in human fatty liver. J Clin Electron Microsc 82:193–202, 1985

    Google Scholar 

  16. Stone BG, Van Thiel DH: Diabetes Mellitus and Liver. In Seminars in Liver Disease. DH Van Thiel (ed). New York, Thieme, 1985, pp 8–28

    Google Scholar 

  17. Balasse EO, Bier DM; Havel RJ: Early effects of anti-insulin serum on hepatic metabolism of plasma free fatty acids in dogs. Diabetes 21(5):280–288, 1972

    Google Scholar 

  18. Heimberg M, Weinstein I, Kohout M: The effects of glucagon, dibutyril cyclic adenosine 3´,5´-monophoshate, and concentration of free fatty acid on hepatic lipid metabolism. J Biol Chem 244(19):5131–5139, 1969

    Google Scholar 

  19. Abram JJ, Ginsberg H, Grundy SM Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 31(10):903–910, 1982

    Google Scholar 

  20. Ishi H: Fatty liver. In The Internal Medicine. T Sugimoto, M Omata (eds). Tokyo, Asakura Shoten, 1999, pp 1034–1036 (in Japanese)

    Google Scholar 

  21. Sherlock S, Dooley J: Nutritional and metabolic liver diseases. In Diseases of the Liver and Biliary System. London, Blackwell Science, pp 427–454

  22. Alpers DH, Sabesin SM: Fatty liver: Biochemical and clincal aspects. In Disease of Liver. L Schiff, ER Schiff (eds). Philadelphia, JB Lippincott, 1987, pp 949–978

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mukai, M., Ozasa, K., Hayashi, K. et al. Various S-GOT/S-GPT Ratios in Nonviral Liver Disorders and Related Physical Conditions and Life-Style. Dig Dis Sci 47, 549–555 (2002). https://doi.org/10.1023/A:1017959801493

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017959801493

Navigation